entertainment -WSS

entertainment

author：explore 2025-08-28 08:47:03 - browse：21798

Amedisys -- Hospital coverage from STAT — Option Care Health is buying Amedisys, creating a national company that specializes in almost all types of home care. Wikimedia Commons

Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 billion, creating a national company that specializes in almost all types of home care that can be provided from cradle to grave.

Health insurance companies, providers, and patients have pushed for more care to be handled at home instead of a hospital or post-acute facility, under the idea that quality home care saves money and is what patients want. Option Care’s deal for Amedisys marks another instance of this push, and comes just a few months after UnitedHealth Group closed on its $5.4 billion acquisition of LHC Group.

But Wall Street was not receptive to the deal, driving down Option Care’s stock by more than 25% on Thursday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： 4 missing after record

WSS

My chronic pain journey would have been easier knowing 5 things % STAT

Study finds gene variants tied to breast cancer risk in Black women

Sophia Smith scores twice for US in in 3

Listen: More tumult at BIO & coercive care for sickle cell patients

Liver decline slowed by off

ASCO eve: Let’s set the table for this year's meeting

focus

entertainment

focus

Medical leaders decry Supreme Court decision on affirmative action

For longer

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Continuity nursing helped my family in our darkest PICU moments

FDA approves first blood sugar monitor without finger pricks

Moonlake's readout produced a cash windfall. Risks remain

FDA approves first blood sugar monitor without finger pricks

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Men with early prostate cancer can safely opt out of treatment

hotspot

UnitedHealth argues against case alleging wrongful AI care denials

Making the case for fair compensation in clinical trials

UnitedHealth argues against case alleging wrongful AI care denials

Biogen joins immunology wave with $1.15 billion acquisition of HI

Digital health: a case of mistaken identity

Study finds gene variants tied to breast cancer risk in Black women

hotspot

hotspot

hotspot

focus